BRBR · BellRing Brands
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $12.67
Note written ·
Price against the kill line
16.7% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $12.67, on record since 11 November 2026. The shares are up 3.7% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $12.67, the 200-day average of closes (11 November 2026), would show the shares leading the S&P 500 and prove this call wrong.
Research onlyNot in the portfolio.
Catalyst
Key figures from the filings · Consumer Staples
Quarter to 30 June 2026, filed 4 August 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 570
- Revenue, change on a year (%)
- +4.2
- Gross margin (%)
- 28.6
- Operating margin (%)
- 11.5
- Free cash flow, four quarters ($M)
- 225
- Net cash, cash less debt ($M)
- −1,085
- Price to earnings (×)
- 7.2
- Enterprise value to sales (×)
- 1.0
All filed numbers
What BellRing Brands reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 570 | +4.2 | 28.6 | 11.5 |
| first filed | 599 | +1.8 | 27.0 | 11.0 |
| first filed | 537 | +0.8 | 29.9 | 14.6 |
| first filed | 648 | +16.6 | 28.9 | 15.8 |
| first filed | 548 | +6.2 | 35.4 | 8.2 |
| first filed | 588 | +18.9 | 32.3 | 16.2 |
| Pre-tax income ($M) | 45.5 |
| Net income ($M) four quarters: 171 | 34.2 |
| Diluted shares, change on a year (%) against the quarter to 30 June 2025 | −8.9 |
| Operating cash flow ($M) | 234 |
| Capital spending ($M) | 9.1 |
| Free cash flow ($M) | 225 |
| Cash and short-term investments ($M) | 50.4 |
| Debt ($M) long-term debt | 1,135 |
| Net cash, cash less debt ($M) | −1,085 |
| Deferred revenue ($M) | Not reported |
| Backlog, orders not yet delivered ($M) | Not reported |
| Receivables ($M) | 216 |
| Inventory ($M) | 481 |
| Shareholders' equity ($M) | −467 |
| Market value ($M) | 1,228 |
| Enterprise value, market value plus net debt ($M) | 2,313 |
| Enterprise value to sales (×) | 1.0 |
| Enterprise value to operating income (×) | 7.4 |
| Price to earnings (×) | 7.2 |
| Price to book value (×) | Not meaningful |
| Free-cash-flow yield (%) | 18.3 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 10.6% of shares outstanding sold short, 2.7 days of average trading to cover, +0.6% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $20K | $0 |
| 12 monthsfrom | $92K | $123K |
The thesis
BellRing Brands' recovery case is still unproven at a $10.17 close on 10 November 2026. The October price increases on Premier Protein shakes and powders are the repair mechanism, and the fiscal fourth-quarter report on 18 November 2026, with the first fiscal 2027 outlook, settles whether they work.
That report tests the $275–295 million adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) outlook set on 4 August 2026. It is also the first outlook issued under Michael Axelrod, who became chief executive on 29 July 2026.
The narrative is dead as a growth story: the 4 August 2026 guidance cut broke it, and the rebound from the $7.43 close of 2 October 2026 to $10.17 has no reported business result behind it. Adjusted daily closes put the shares 69.5% below the 52-week high of $33.30 and 7.5% lower over three months. The 14-day relative strength index (RSI) is 60.9, down from 69.0 on 28 October 2026.
The company confirmed on 27 October 2026 that it will report at 7:00 a.m. ET on Wednesday 18 November 2026, with a call at 8:30 a.m. ET. No company news, SEC filing or analyst rating change dated after 28 October 2026 turned up in a search on 11 November 2026.
Bullish and bearish views on BellRing Brands, Inc.
The bull case on BellRing Brands, Inc. (BRBR), in brief: Sales kept growing through the profit reset. The bear case: analyst targets kept moving lower into the report.
Bull case
- Sales kept growing through the profit reset. Fiscal third-quarter net sales were $570.4 million on 4 August 2026, above the $547.762 million consensus. Fiscal 2026 net-sales guidance rose to $2.335–2.375 billion from $2.325–2.365 billion.
- Pricing has a company precedent. Dymatize sales rose 26.7% in the fiscal third quarter, with volume up 6.0% and price/mix up 20.7%, per the 4 August 2026 release. Management said on the earnings call that a double-digit Premier shake price increase and more powder pricing were planned for the first quarter of fiscal 2027.
- Consumer demand held up at retail. FoodNavigator reported on 5 August 2026 that Premier Protein ready-to-drink consumption rose 6% and Dymatize 3% in the quarter, per the company's own figures.
- Two covering firms still rate the shares Overweight. JPMorgan (Overweight, $15 target, 27 October 2026) and Barclays (Overweight, $12 target, 16 October 2026) cut targets but kept their ratings, per Benzinga. Both targets sit above the $10.17 close.
- The shares have recovered from the autumn low. The close was $7.43 on 2 October 2026, $9.29 on 28 October 2026 and $10.17 on 10 November 2026, per adjusted daily closes.
Bear case
- Analyst targets kept moving lower into the report. TD Cowen cut to $9 with a Hold rating on 13 October 2026, Barclays to $12 on 16 October 2026, and JPMorgan to $15 on 27 October 2026, all per Benzinga. TD Cowen's $9 target sits below the $10.17 close.
- Promotions carried shake volume. Premier Protein ready-to-drink shake volume rose 3.1% while price/mix fell 1.9% in the quarter reported 4 August 2026. The company attributed the weaker mix to incremental promotional spending.
- Margins fell short of guidance. Third-quarter adjusted EBITDA was $78.3 million, a 13.7% margin, against roughly 16% guided on 5 May 2026. Management cited an excess shake-bottle inventory charge and higher freight costs.
- Inventory and leverage are heavy. Inventories were $480.6 million at 30 June 2026 versus $330.4 million at 30 September 2025. Cash was $50.4 million and long-term debt $1,135.3 million.
- Legal overhang. A securities class action alleging retailer inventory stockpiling is pending. Several law firms announced director-and-officer investigations in August 2026.
Price setup
Adjusted daily closes show the shares at $10.17 on 10 November 2026. That is above the $7.43 close of 2 October 2026, which is the autumn low, and far under the 52-week high of $33.30.
The shares closed at $9.29 on 28 October 2026, so most of the rebound came before the report date was a week or two away. RSI of 60.9 is a reading in the upper half of the range, not an extreme.
The next test is the 18 November 2026 report. The shares trade in a range set by the autumn low and the TD Cowen $9 target on the downside and the Barclays $12 and JPMorgan $15 targets on the upside. A close above $12 would put the shares above the lower of the two Overweight targets.
Crowding evidence is limited to an imminent earnings date, which sits eight days after the 10 November 2026 close. No insider transactions or share issuance appear in SEC filings after 28 October 2026.
Catalysts ahead
- 18 November 2026: Fiscal 2026 fourth-quarter and full-year results with the first fiscal 2027 outlook (7:00 a.m. ET release, 8:30 a.m. ET call). Tests the $275–295 million adjusted EBITDA outlook, inventory normalization and the Premier price increase, and gives the first outlook under the new chief executive.
What would change the view
A daily close above $12.67, the 200-day average of closes (11 November 2026), would show the shares leading the S&P 500 and prove this call wrong.
What it trades with
Sales depend heavily on Premier Protein ready-to-drink shakes, so club and mass-retail resets move the shares more than broad market direction. Protein-brand peers and packaged-food names carry the same retailer-inventory and promotion questions.
The shares trade on the company's own guidance and on analyst target changes, as the 4 August 2026 guidance cut and the three target cuts of October 2026 show. A single quarter's report is the main event for the next three months.
The evidence, claim by claim (8)
- Fiscal 2026 adjusted EBITDA outlook lowered to $275–295M from $315–335M; net-sales guidance raised to $2.335–2.375B from $2.325–2.365B. BellRing Q3 FY2026 earnings release · as of
- Q3 FY2026 net sales $570.4M versus $547.762M consensus; adjusted EBITDA $78.3M, a 13.7% margin versus roughly 16% guided on 5 May 2026. BellRing Q3 FY2026 earnings release · as of
- Inventories $480.6M versus $330.4M at 30 September 2025; cash $50.4M; long-term debt $1,135.3M; stockholders' deficit $(467.2)M. Q3 FY2026 earnings release balance sheet · as of
- BellRing will report fourth-quarter and fiscal 2026 results and the fiscal 2027 outlook on 18 November 2026 at 7:00 a.m. ET, with a call at 8:30 a.m. ET. BellRing press release via GlobeNewswire/Yahoo Finance · as of
- JPMorgan maintained Overweight and lowered its BellRing price target to $15. Benzinga · as of
- Barclays maintained Overweight and lowered its BellRing price target to $12. Benzinga · as of
- TD Cowen maintained Hold and lowered its BellRing price target to $9. Benzinga · as of
- Adjusted daily close $10.17; 52-week high $33.30; three-month change −7.5%; RSI(14) 60.9. Split/dividend-adjusted daily bars · as of
Sources